Aprea Therapeutics Operating Margin Growth & History (APRE)
Aprea Therapeutics's operating margin was −4,631.12% for fiscal 2025.
View full Aprea Therapeutics company overviewAprea Therapeutics annual operating margin history
2023
2024
2025
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −4,631.12% | −3678.11 pp |
| 2024 | 2024-12-31 | −953.00% | +1699.80 pp |
| 2023 | 2023-12-31 | −2,652.80% | — |
Aprea Therapeutics quarterly operating margin
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −79,205.66% | −77638.23 pp |
| Q3 2025 | 2025-09-30 | −168,689.83% | −167534.50 pp |
| Q2 2025 | 2025-06-30 | −2,868.30% | −2183.27 pp |
| Q1 2025 | 2025-03-31 | −2,514.78% | −1687.16 pp |
| Q4 2024 | 2024-12-31 | −1,567.43% | — |
| Q3 2024 | 2024-09-30 | −1,155.32% | −52.60 pp |
| Q2 2024 | 2024-06-30 | −685.03% | +777.47 pp |
| Q1 2024 | 2024-03-31 | −827.62% | — |
| Q3 2023 | 2023-09-30 | −1,102.72% | — |
| Q2 2023 | 2023-06-30 | −1,462.50% | — |
Aprea Therapeutics operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Aprea Therapeutics's operating margin decreased from −2,652.80% to −4,631.12%, a change of −1978.32 percentage points. The latest reported quarter, Q4 2025, shows −79,205.66%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aprea Therapeutics source filings ↗